High celecoxib-loaded nanoparticles prepared by a vibrating nozzle device

References

• Ahlin P, Kristl J, Kristl A, Vrečer F. Investigation of polymeric nanoparticles as carriers of enalaprilat for oral administration. Int J Pharm 2002; 239: 113–120
   PubMed Web of Science ®Google Scholar
• Allemann E, Leroux JC, Gurnay R, Doelker E. In vitro extended-release properties of drug-loaded poly (D,L-lactic acid) nanoparticles produced by a salting-out procedure. Pharm Res 1993; 10: 1732–1737
   PubMed Web of Science ®Google Scholar
• Alonso MJ. Nanoparticulate drug carrier technology. Pharmaceutical dosage forms: Disperse systems, HA Lieberman, MM Rieger, GS Benker. Marcel Dekker, New York 1996; 1: 203–242
   Google Scholar
• Arangoa MA, Companero MA, Renedo MJ, Ponchet G, Irache JM. Gliadin nanoparticles as carriers for the oral administration of lipophilic drugs. Relationships between bioadhesion and pharmacokinetics. Pharm Res 2001; 18: 1521–1527
   PubMed Web of Science ®Google Scholar
• Budhian A, Siegel SJ, Winey KI. Haloperidol-loaded PLGA nanoparticles: Systematic study of particle size and drug content. Int J Pharm 2007; 336: 367–375
   PubMed Web of Science ®Google Scholar
• Dong Y, Feng SS. Methoxy poly(ethylene glycol)-poly(lactide) (MPEG-PLA) nanoparticles for controlled delivery of anticancer drugs. Biomaterials 2004; 25: 2843–2849
   PubMed Web of Science ®Google Scholar
• Fessi H, Puisieux F, Devissaguet JP, Ammoury N, Benita S. Nanocapsule formation by interfacial polymer deposition following solvent displacement. Int J Pharm 1989; 55: R1–R4
   Web of Science ®Google Scholar
• Galindo-Rodríguez SA, Puel F, Briançon S, Allémann E, Doelker E, Fessi H. Comparative scale-up of three methods for producing ibuprofen-loaded nanoparticles. Eur J Pharm Sci 2005; 25: 357–367
   PubMed Web of Science ®Google Scholar
• Gorner T, Gref R, Michenot D, Sommer F, Tran MN, Dellacherie E. Lidocaine-loaded biodegradable nanospheres. I. Optimization of the drug incorporation into the polymer matrix. J Contr Rel 1999; 57: 259–268
   PubMed Web of Science ®Google Scholar
• Govender T, Stolnik S, Garnett MC, Illum L, Davis SS. PLGA nanoparticles prepared by nanoprecipitation: Drug loading and release studies of a water soluble drug. J Contr Rel 1999; 57: 171–185
   PubMed Web of Science ®Google Scholar
• Hariharan S, Bhardwaj V, Bala HI, Sitterberg J, Bakowsky U, Ravi Kumar MNV. Design of estradiol loaded PLGA nanoparticulate formulations: A potential oral delivery system for hormone therapy. Pharm Res 2006; 23: 184–195
   PubMed Web of Science ®Google Scholar
• Homar M, Ubrich N, El Ghazouani F, Kristl J, Kerč J, Maincent P. Influence of polymers on the bioavailability of microencapsulated celecoxib. J Microencapsulation 2007; 24: 621–633
   PubMed Web of Science ®Google Scholar
• Jain RA. The manufacturing techniques of various drug-loaded biodegradable poly(lactide-co-glycolide) (PLGA) devices. Biomaterials 2000; 21: 2475–2490
   PubMed Web of Science ®Google Scholar
• Jeon HJ, Jeong YI, Jang MK, Park YH, Nah JW. Effect of solvent on the preparation of surfactant-free poly(-lactide-co glycolide) nanoparticles and norfloxacin release characteristics. Int J Pharm 2000; 207: 99–108
   PubMed Web of Science ®Google Scholar
• Konan YN, Gurny R, Allemann E. Preparation and characterization of sterile and freeze-dried sub-200 nm nanoparticles. Int J Pharm 2002; 233: 239–252
   PubMed Web of Science ®Google Scholar
• Kristl J, Allemann E, Gurny R. Formulation and evaluation of zinc-phthalocyanine loaded poly(D,L-lactic acid) nanoparticles. Acta Pharm 1996; 46: 1–12
   Google Scholar
• Lamprecht A, Schafer U, Lehr CM. Size-dependent bioadhesion of micro- and nanoparticulate carriers to the inflammed colonic mucosa. Pharm Res 2001; 18: 788–793
   PubMed Web of Science ®Google Scholar
• Leroux JC, Cozens R, Roesel JL, Galli B, Kubel F, Doelker E, et al. Pharmacokinetics of a novel HIV-1 protease inhibitor incorporated into biodegradable or enteric nanoparticles following intravenous and oral administration to mice. J Pharm Sci 1995; 84: 1387–1391
   PubMed Web of Science ®Google Scholar
• Panyam J, Williams D, Dash A, Leslie-Pelecky D, Labhasetwar V. Solid-state solubility influences encapsulation and release of hydrophobic drugs from PLGA/PLA nanoparticles. J Pharm Sci 2004; 93: 1804–1814
   PubMed Web of Science ®Google Scholar
• Piñón-Segundo E, Ganem-Quintanar A, Alonso-Pérez V, Quintanar-Guerrero D. Preparation and characterization of triclosan nanoparticles for periodontal treatment. Int J Pharm 2005; 294: 217–232
   PubMed Web of Science ®Google Scholar
• Pluess-Wenzinger R, Widmer F, Heinzen C, Brandenberger H. Method and device for capsulating microbal, plant and animal cells or biological and chemical substances. 2000, EP1062032. Inotech AG
   Google Scholar
• Radwan MA. In vitro evaluation of polyisobutylcyanoacrylate nanoparticles as a controlled drug carrier for theophylline. Drug Dev Ind Pharm. 1995; 22: 2371–2375
   Google Scholar
• Sahana DK, Mittal G, Bhardway V, Ravi Kumar MNV. PLGA nanoparticles for oral delivery of hydrophobic drugs: Influence of organic solvent on nanoparticle formation and release behaviour in vitro and in vivo using estradiol as a model drug. J Pharm Sci 2008; 97: 1530–1542
   PubMed Web of Science ®Google Scholar
• Sahoo SK, Panyam J, Prabha S, Labhasetwar V. Residual polyvinyl alcohol associated with poly (D, L-lactide-co-glycolide) nanoparticles affects their physical properties and cellular uptake. J Contr Rel 2002; 82: 105–114
   PubMed Web of Science ®Google Scholar
• Zeisser-Labouèbe M, Lange N, Gurny R, Delie F. Hypericin-loaded nanoparticles for the photodynamic treatment of ovarian cancer. Int J Pharm 2006; 326: 174–181
   PubMed Web of Science ®Google Scholar